Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hydrotalea sp. AMD isolate:AMD

ABSTRACT: Hydrotalea sp. AMD isolate:AMD Genome sequencing and assembly

PROVIDER: PRJNA513256 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SCKY01.dat.gz	Other
	SCKY01.fasta.gz	Fasta.gz
	SCKY01.master.dat	Other

Items per page:

1 - 4 of 4

Similar Datasets

Hydrotalea

Project description:Hydrotalea sp. overview

| PRJNA746651 | ENA

Acidithiobacillus sp. 'AMD consortium'

Project description:Acidithiobacillus sp. 'AMD consortium' Genome sequencing

| PRJNA573091 | ENA

Proteogenomic of Blastocystis sp. subtype 4 isolate WR1

Project description:description Blastocystis sp. is a highly prevalent anaerobic eukaryotic parasite of humans and animals. The genome of several representatives has been sequenced revealing specific traits such as an intriguing 3’-end processing of primary transcripts. We have acquired a first high-throughput proteomics dataset on the difficult to cultivate ST4 isolate WR1 and detected 2,761 proteins. We evidenced for the first time by proteogenomics a functional termination codon derived from transcript polyadenylation for seven different key cellular components.

2017-09-11 | PXD006588 | Pride

Hydrotalea lipotrueae strain:TMF_100

Project description:Hydrotalea lipotrueae strain:TMF_100 Genome sequencing and assembly

| PRJNA692363 | ENA

Hydrotalea flava strain:CCUG 51397

Project description:Hydrotalea flava strain:CCUG 51397 Genome sequencing and assembly

| PRJNA302607 | ENA

Hydrotalea sandarakina strain:DSM 23241

Project description:Hydrotalea sandarakina DSM 23241

| PRJNA262268 | ENA

Human AMD

Project description:Human AMD

| PRJNA648863 | ENA

AMD

Project description:AMD Raw sequence reads

| PRJNA1097011 | ENA

DNA methylation profiles in the retina of AMD patients

Project description:Age-related macular degeneration (AMD) is a major cause of blindness in the western world. While genetic studies have linked both common and rare variants in genes involved in regulation of the complement system to increased risk of development of AMD, environmental factors, such as smoking and nutrition, can also significantly affect the risk of developing the disease and the rate of disease progression. Since epigenetics has been implicated in mediating, in part, the disease risk associated with some environmental factors, we investigated a possible epigenetic contribution to AMD. We performed genome-wide DNA methylation profiling of blood from AMD patients and controls. No differential methylation site reached genome-wide significance; however, when epigenetic changes in and around known GWASdefined AMD risk loci were explored, we found small but significant DNA methylation differences in the blood of neovascular AMD patients near age-related maculopathy susceptibility 2 (ARMS2), a top-ranked GWAS locus preferentially associated with neovascular AMD. The methylation level of one of the CpG sites significantly correlated with the genotype of the risk SNP rs10490924, suggesting a possible epigenetic mechanism of risk. Integrating genome-wide DNA methylation analysis of retina samples with and without AMD together with blood samples, we further identified a consistent, replicable change in DNA methylation in the promoter region of protease serine 50 (PRSS50). These methylation changes may identify sites in novel genes that are susceptible to non-genetic factors known to contribute to AMD development and progression.

2017-08-23 | GSE102952 | GEO

Project description:WTCCC2 project Schizophrenia (SP) samples

| EGAD00010000262 | EGA